HS 300490 Buyers of Medicines (packaged)
Medicaments; consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale. World imports reached $380.31B in 2023.
Top buyers · Open tenders (30)
Top importing countries
World imports $380.31B (2023, 167 reporting countries, UN Comtrade).
| # | Country | Imports | Share |
|---|---|---|---|
| 1 | USA | $68.99B | 18.1% |
| 2 | Switzerland | $35.32B | 9.3% |
| 3 | Germany | $26.84B | 7.1% |
| 4 | Belgium | $18.98B | 5.0% |
| 5 | China | $17.83B | 4.7% |
| 6 | Italy | $17.41B | 4.6% |
| 7 | United Kingdom | $13.48B | 3.5% |
| 8 | France | $13.35B | 3.5% |
| 9 | Japan | $12.96B | 3.4% |
| 10 | Spain | $12.79B | 3.4% |
Open government tenders
EU, UK and World Bank notices · updated 16 Oct 2026 · check full notice before bidding
- PURCH3013 Provision of Contract Agreement for Manufacture of Investigational Medicinal Products for a Clinical TrialUK Find a Tender · University of Glasgow · United Kingdom · closes 2026-10-19
- CivTech 12.1 - How can digital technologies assist people living with substance use issues (and their families/friends) to easily connect with trusted help and substance use support when services are unavailable?UK Find a Tender · University of Strathclyde · United Kingdom · closes 2026-10-20
- NP47926 Biologic, Biosimilar’s and Methotrexate InjectionsUK Find a Tender · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · United Kingdom · closes 2026-10-21
- NP93827 Seasonal Influenza VaccineUK Find a Tender · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · United Kingdom · closes 2026-11-09
- Womens HealthUK Find a Tender · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · United Kingdom · closes 2026-11-16
- Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-VerfahrenTED (EU) · KKH Kaufmännische Krankenkasse · DEU · closes 2026-12-31
- Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-VerfahrenTED (EU) · KKH Kaufmännische Krankenkasse · DEU · closes 2026-12-31
- Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-VerfahrenTED (EU) · KKH Kaufmännische Krankenkasse · DEU · closes 2026-12-31
+22 more matching tenders in the weekly digest.
Get new Medicines (packaged) buyers every week
Fresh tenders and importer signals for HS 300490, by email. Free.
Need everything now? Buyer Pack, $9–19 (early access)
All open tenders, top 25 importing markets and named buyers for HS 300490, as CSV and PDF. No payment until launch.
Exporting from India? Duty & RoDTEP rates
Basic customs duty (MFN)
10%
Applied MFN rate, 70 tariff line(s), WITS 2023. Excludes AIDC & SWS.RoDTEP (export incentive)
0.7% / 0.8% / 1.1%
DGFT Appendix 4R, w.e.f. 10 Oct 2024.RoDTEP tariff lines (70)
| 30049011 | Of Ayurvedic system | 0.7% | |
| 30049012 | Of Unani system | 0.7% | |
| 30049013 | Of Siddha system | 0.7% | |
| 30049014 | Of Homoeopathic system | 0.7% | |
| 30049015 | Of Bio-chemic system | 0.7% | |
| 30049021 | Anthelmintics and preparations thereof | 0.7% | |
| 30049022 | Metronidazole | 0.7% | |
| 30049023 | Tinidazole | 0.7% | |
| 30049024 | Secnidazole | 0.7% | |
| 30049025 | Diluxamide furoate | 0.7% | |
| 30049026 | Sodium stibogluconate | 0.7% | |
| 30049027 | Pentamidine | 0.7% | |
| 30049029 | Other | 0.7% | |
| 30049031 | Promethazine, chlorpheniramine, astemizole and ceteirizine | 0.7% | |
| 30049032 | Sodium bicarbonate, magnesium hydroxide (milk of | 0.7% | |
| 30049033 | Cimetidine, rantidine, nizatidine and roxatidine | 0.7% | |
| 30049034 | Omeprazole and lansoprazole | 0.8% | |
| 30049035 | Dicyclomine, metoclopramide and dexame thasone and | 0.7% | |
| 30049036 | Chenodiol and ursodiol | 0.7% | |
| 30049039 | Other | 0.7% | |
| 30049041 | Cyclophosphamide | 0.7% | |
| 30049042 | Methotrexate, 5-fluorouracil(5-FU) and ftorafur | 0.7% | |
| 30049043 | Bincristine and vinblastine | 0.7% | |
| 30049044 | Paclitaxel and docetaxel | 0.7% | |
| 30049045 | Etoposide | 0.7% | |
| 30049046 | Actinomycin D Dactinomycin and doxorubicin | 0.7% | |
| 30049047 | L-Asparaginase, cisplatin and carboplatin | 0.7% | |
| 30049048 | Tamoxifen | 0.7% | |
| 30049049 | Other | 0.7% | |
| 30049051 | Isoniazid | 0.7% | |
| 30049052 | Rifampicin | 0.7% | |
| 30049053 | Pyrazinamide and ethambutol | 0.7% | |
| 30049054 | Streptomycin | 0.7% | |
| 30049055 | Dapsone (DDS), acedapsone (DADDS), solopsone and | 0.7% | |
| 30049056 | Chloroquine, amodiaquine, mefloquine, quinine, | 0.7% | |
| 30049057 | Other antitubercular drugs | 0.7% | |
| 30049058 | Other antileprotic drugs | 0.7% | |
| 30049059 | Other antimalarial drugs | 0.7% | |
| 30049061 | Analgin with or without other compounds such as | 0.7% | |
| 30049062 | Acetyl salicylic acid (aspirin) and formulations thereof | 0.7% | |
| 30049063 | Ibuprofen with or without paracetamol or other compounds | 0.7% | |
| 30049064 | Oxyphen butazone, phenyl butazone and formulations | 0.7% | |
| 30049065 | Indomethacin | 0.7% | |
| 30049066 | Mephenamic acid, dactofenac sodium, piroxicam, tenoxicam | 0.7% | |
| 30049067 | Ketorolac, nimesulide, nabumetone and nefopam | 0.7% | |
| 30049069 | Other | 0.7% | |
| 30049071 | Captopril, enalapril, lisinopril, perindopril and ramipril | 0.7% | |
| 30049072 | Verapamil, nifedipine, amlodipine and lacidipine | 0.7% | |
| 30049073 | Losartan | 1.1% | |
| 30049074 | Propranolol, metoprolol, atenolol and labetalol | 0.7% | |
| 30049075 | Prazosin, terazosin, phentolamine and phenoxybenzamine | 0.7% | |
| 30049076 | Clonidine, methyldopa | 0.7% | |
| 30049077 | Hydralazine, minoxidil and diazoxide | 0.7% | |
| 30049079 | Other | 0.7% | |
| 30049081 | Phenobarbitone, mephobarbitone, primidone, phenytoin, | 0.7% | |
| 30049082 | Other antiepileptic drugs | 0.7% | |
| 30049083 | Sulpha drugs not elsewhere specified or included | 0.7% | |
| 30049084 | Preparations of enzymes | 0.7% | |
| 30049085 | Veterinary medicinal preparations, not for human use, not | 0.7% | |
| 30049086 | Oral rehydration salts | 0.7% | |
| 30049087 | Antibacterial formulations, not elsewhere specified or | 0.7% | |
| 30049088 | Sedatives | 0.7% | |
| 30049089 | Tranquilizers | 0.7% | |
| 30049091 | Salbutamol, terbutaline, ephedrine, salmeterol and methyl | 0.7% | |
| 30049092 | Plasma expanders | 0.7% | |
| 30049093 | Chloropheniramine maleate, with or without other | 0.7% | |
| 30049094 | Theophylline, aminophylline and other broncho dilators | 0.7% | |
| 30049095 | Carcino-chemotherapeutic drugs not elsewhere specified or | 0.7% | |
| 30049096 | Ketamine | 0.7% | |
| 30049099 | Other | 0.7% |